Report
Jonathan Moreland
EUR 9.28 For Business Accounts Only

InsiderInsights Daily Ratings Report: July 17, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
Angi Inc. Class A

ANGI Homeservices connects homeowners to home service professionals through its portfolio of digital home services brands. The company has two segments: North America (United States and Canada), which includes HomeAdvisor digital marketplace service (HomeAdvisor), Angie's List, its subsidiary, Handy Technologies, Inc. (Handy), mHelpDesk and HomeStars; and Europe, which includes Travaux, MyHammer, My Builder, Werkspot and Instapro. HomeAdvisor provides consumers with tools and resources to help them find local, pre-screened and customer-rated service professionals, as well as book appointments online. Handy connects individuals looking for household services with pre-screened service professionals.

Collegium Pharmaceutical Inc.

Collegium Pharmaceuticals is a pharmaceutical company focused on pain management. The company's lead product, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the U.S. Food and Drug Administration for the management of pain. The company's product portfolio also includes Nucynta ER, an extended-release formulation of tapentadol for the management of pain including neuropathic pain associated with diabetic peripheral neuropathy in adults; and Nucynta IR, an immediate-release formulation of tapentadol that is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults.

Inuvo Inc

Inuvo is an internet advertising technology and digital publishing company that develops technology to deliver content and advertisements over the internet. The company has two segments: Partner Network, which recruits online publishers and provides them an advertising delivery service, the primary brands for which are ValidClick and SearchLinks©; and Owned and Operated Network, which designs, builds and markets consumer websites and applications, and is consists of the company's main online property marketed under the ALOT brand and a number of other websites targeted at demographics like EARNSPENDLIVE and sites designed for generating leads in a specific market vertical like ASKTHIS for automotive.

LeMaitre Vascular Inc.

LeMaitre Vascular is a provider of medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons. The company's portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and includes the LeMaitre valvulotome, the XenoSure biologic patch, the Pruitt F3 carotid shunt, VascuTape radiopaque tape, and Syntel embolectomy catheters. The company's principal product offerings are sold throughout the world, primarily in the United States, Europe and Asia/Pacific Rim.

OncoSec Medical

OPKO Health Inc.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Rubius Therapeutics

Rubius Therapeutics is a therapeutics company focused on using its platform to develop red cell therapeutics for the treatment of patients with severe diseases. The company is developing a class of cellular medicines, called Red Cell Therapeutics? for patients with cancer and autoimmune diseases based on two therapeutic modalities - potent cell-cell interaction and tolerance induction. The company's product candidates pipeline comprised of: RTX-240 for the treatment of solid tumors; RTX-240 for the treatment of acute myeliod leukemia; RTX-321 artificial antigen presenting cell program for the treatment of solid tumors; RTX-224 for the treatment of solid tumors; and RTX-T1D for the treatment of diabetes.

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch